Harmony Biosciences Holdings (HRMY) Retained Earnings (2019 - 2026)
Harmony Biosciences Holdings' (HRMY) quarterly Retained Earnings came in at -$413000.0 in Q1 2026, down 100.86% year-on-year from $47.8 million in Q1 2025, and down 100.26% quarter-over-quarter from $160.9 million in Q4 2025.
Harmony Biosciences Holdings (HRMY) Retained Earnings (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has disclosed Retained Earnings across 8 years of filings, most recently posting -$413000.0 for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$413000.0, down 100.86% year-over-year; the trailing twelve-month figure through Mar 2026 was -$413000.0 (down 100.86% YoY), and the FY2025 annual result was $160.9 million, up 7160.97% from the prior year.
- Retained Earnings came in at -$413000.0 for Q1 2026 at Harmony Biosciences Holdings, down from $160.9 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $160.9 million in Q4 2025 to a low of -$432.1 million in Q1 2022.
- The 5-year median for Retained Earnings is -$178000.0 (2022), against an average of -$25.3 million.
- Across the five-year window, Retained Earnings plunged 338425.81% in 2024 and jumped 37515.38% in 2025, its largest moves.
- Harmony Biosciences Holdings' Retained Earnings stood at -$151000.0 in 2022, then slumped by 94785.43% to -$143.3 million in 2023, then soared by 101.55% to $2.2 million in 2024, then jumped by 7160.97% to $160.9 million in 2025, then sank by 100.26% to -$413000.0 in 2026.
- The last three Retained Earnings figures came in at -$413000.0 (Q1 2026), $160.9 million (Q4 2025), and $357000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Harmony Biosciences Holdings | 1.92 Bn | 1.28 Bn | 170.88 Mn | -413,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -413,000.00 |
| Dec 31, 2025 | 160.90 Mn |
| Sep 30, 2025 | 357,000.00 |
| Jun 30, 2025 | 87.55 Mn |
| Mar 31, 2025 | 47.78 Mn |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | -47.26 Mn |
| Jun 30, 2024 | -234,000.00 |
| Mar 31, 2024 | -104.94 Mn |
| Dec 31, 2023 | -143.28 Mn |
| Sep 30, 2023 | -516,000.00 |
| Jun 30, 2023 | -522,000.00 |
| Mar 31, 2023 | -31,000.00 |
| Dec 31, 2022 | -151,000.00 |
| Sep 30, 2022 | -178,000.00 |
| Jun 30, 2022 | -29,000.00 |
| Mar 31, 2022 | -432.11 Mn |
| Dec 31, 2021 | -453.60 Mn |
| Sep 30, 2021 | -476.31 Mn |
| Jun 30, 2021 | -466.69 Mn |